Radexel is pioneering a fusion solution that combines radiation therapy with advanced magnetic control technology.
We are building an optimized medical device ecosystem tailored to diverse clinical needs: the 'Modular Add-on (MPRT-SD)' for upgrading existing systems,
the 'Integrated All-in-One (MPRT-IS)' for complete treatment solutions,
and the 'Robotic System (MPRT-RB)' for precise, targeted therapy.
Cost Efficiency & Accessibility
Maximizing Efficiency
We aim to resolve the challenges of high acquisition costs and limited efficiency associated with modern radiation therapy systems.
High costs often restrict patient access to necessary treatments.
Radexel is driving technological innovation to enhance cost-efficiency, creating an environment where more patients can receive timely and effective care.
Precision & Safety
Targeting via Magnetic Control
Our Magnetic-Radiation Fusion Technology controls the path and distribution of radiation beams using magnetic fields.
This system is designed to concentrate the radiation dose precisely on the tumor while minimizing exposure to surrounding healthy organs.
We aim to deliver superior precision compared to conventional methods while alleviating the economic burden on patients.
Technology Leadership
Robust IP Portfolio & Validation
Radexel holds the world’s largest portfolio of foundational patents in magnetic-radiation fusion therapy.
We have successfully completed prototype development and pre-clinical validation, proving the feasibility of our technology.
As a global frontrunner, we are now focused on refining and advancing this cutting-edge technology.